Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 791-794 |
Número de páginas | 4 |
Publicación | International Journal of Tuberculosis and Lung Disease |
Volumen | 25 |
N.º | 10 |
DOI | |
Estado | Publicada - 1 oct. 2021 |
Tipos de Productos Minciencias
- Artículos de investigación con calidad A1 / Q1
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
Acceder al documento
Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
En: International Journal of Tuberculosis and Lung Disease, Vol. 25, N.º 10, 01.10.2021, p. 791-794.
Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva
TY - JOUR
T1 - Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB
AU - Köser, C. U.
AU - Robledo, J.
AU - Shubladze, N.
AU - Schön, T.
AU - Dolinger, D. L.
AU - Salfinger, Max
N1 - Funding Information: CUK received an observership by the European Society of Clinical Microbiology and Infectious Diseases. JR is funded by Ministerio de Ciencia Tecnología e Innovación, Bogotà, Colombia (No. 221389666216 CT-783-2018). CUK is a research associate at Wolfson College, University of Cambridge, and visiting scientist at the Department of Genetics, University of Cambridge, Cambridge, UK. TS is funded by the Swedish Heart and Lung Foundation, Stockholm, and the Swedish Research Council, Stockholm, Sweden. Conflicts of interest: CUK's consulting work for Becton Dickinson involves a collaboration with Janssen, Beerse, Belgium; and Thermo Fisher Scientific, Waltham, MA, USA. CUK also consults for the Foundation for Innovative New Diagnostics, Geneva, Switzerland; and the TB Alliance, New York, NY, USA. CUK worked as a consultant for QuantuMDx, Newcastle upon Tyne, UK; the Stop TB Partnership, Geneva, Switzerland; the WHO Global TB Programme, Geneva, Switzerland; and the WHO Regional Office for Europe, Copenhagen, Denmark. CUK gave a paid educational talk for Oxford Immunotec, Abingdon, UK. Hain Lifescience covered CUK's travel and accommodation to present at a meeting. CUK is an unpaid advisor to BioVersys, Basel, Switzerland; and GenoScreen, Lille, France. JR gave a paid talk for bioMérieux, Marcy l'Etoile, France, and received funding from BD, Franklin Lakes, NJ, USA. DLD works for PhAST, Cambridge, MA, USA. DLD also provides consulting services for Molbio Diagnostics, Verna, India; Partners in Health, Boston, MA, USA; and Médecins Sans Frontières, Paris, France. DLD worked for QuantuMDx. Funding Information: CUK received an observership by the European Society of Clinical Microbiology and Infectious Diseases. JR is funded by Ministerio de Ciencia Tecnología e Innovación, Bogotà, Colombia (No. 221389666216 CT-783-2018). CUK is a research associate at Wolfson College, University of Cambridge, and visiting scientist at the Department of Genetics, University of Cambridge, Cambridge, UK. TS is funded by the Swedish Heart and Lung Foundation, Stockholm, and the Swedish Research Council, Stockholm, Sweden.
PY - 2021/10/1
Y1 - 2021/10/1
UR - http://www.scopus.com/inward/record.url?scp=85117003484&partnerID=8YFLogxK
U2 - 10.5588/ijtld.21.0428
DO - 10.5588/ijtld.21.0428
M3 - Artículo de revisión
C2 - 34615575
AN - SCOPUS:85117003484
SN - 1027-3719
VL - 25
SP - 791
EP - 794
JO - International Journal of Tuberculosis and Lung Disease
JF - International Journal of Tuberculosis and Lung Disease
IS - 10
ER -